is this a buying opportunity for opk?
I think it is. They are doing same thing for people who wanted to enter OPK as Citron did for those who missed out on VJET run.
Short covering is coming
IT GETS WORSE. Remove what people use constantly and replace them with anaphylactic none sense nobody wants
I was in at $16, and still holding my 5000 shares of AMAVF
The same characteristics are unfolding with NNVC.
What an opportunity I missed, being in the Med field, and knowing they were developing Hep B treatment, not available anywhere else. HIV met it's match with GILD. I applaud you guys at Gilead.